21
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.161
Exchange
XHKG - Hong Kong Exchange
-0.064 B
Last period CFO ,CNY
53%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Mabpharm
Company Analysis
2181.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2181.HK financial analysis by Eyestock methodology
Valuation
2181.HK valuation using historical relative method
Statements
2181.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2181.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Mabpharm`s CFO for the period ended 2024-06-30 is -0.064 B CNY
